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Abstract
We  encountered  a  60-year-old  woman  with  a  medical  history  of  diabetes  mellitus, 
osteoporosis, peripheral vascular disease, and hypertension who had earlier presented at an 
outside facility with knee pain, which led to a finding of elevated neutrophil count of 35× 
10
9/L. Because she was otherwise asymptomatic but continued showing elevated neutrophil 
levels, she sought a second opinion at our facility. Serum protein immunoelectrophoresis with 
immunofixation  revealed  an  immunoglobulin  A  (IgA)
concentration of 1305 mg/dL (normal 80
IgG  of  840 mg/dL (620-1400  mg/dL) and  IgM  of  36  mg/dL (45
analysis, we found a polyclonal expression pattern in all cell types analyzed. Comprehensive
work-up  for  multiple  myeloma  and  infectious  etiology  of  neutrophilia  was  negative.  We 
concluded that our patient’s neutrophilia may have been due to the underlying monoclonal 
gammopathy. This is the first case in the literature of a patient with monoclona
of  undetermined  significance  presenting  with  chronic  neutrophilia,  mimicking  chronic 
neutrophilic  leukemia  (CNL).  Patients  with  CNL  have  a  poor  prognosis;  therefore,  it  is 
important to distinguish diagnostically between CNL and reactive neutro
Introduction:  Monoclonal  gammopathy  of 
undetermined significance (MGUS), as defined by 
the  International  Myeloma  Working  Group,  is  a 
disorder characterized by a prominent monoclonal 
protein  identified  by  serum  electrophoresis.    In 
MGUS,  the  serum  monoclonal  protein 
concentration is <30 g/L and the incidence of bone 
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old  woman  with  a  medical  history  of  diabetes  mellitus, 
osteoporosis, peripheral vascular disease, and hypertension who had earlier presented at an 
outside facility with knee pain, which led to a finding of elevated neutrophil count of 35× 
cause she was otherwise asymptomatic but continued showing elevated neutrophil 
levels, she sought a second opinion at our facility. Serum protein immunoelectrophoresis with 
immunofixation  revealed  an  immunoglobulin  A  (IgA)-κ  monoclonal  gammopathy 
tion of 1305 mg/dL (normal 80-350 mg/dL) but relatively normal concentrations of 
1400  mg/dL) and IgM of  36 mg/dL (45-250  mg/dL).  Using  clonal 
analysis, we found a polyclonal expression pattern in all cell types analyzed. Comprehensive
up  for  multiple  myeloma  and  infectious  etiology  of  neutrophilia  was  negative.  We 
concluded that our patient’s neutrophilia may have been due to the underlying monoclonal 
gammopathy. This is the first case in the literature of a patient with monoclona
of  undetermined  significance  presenting  with  chronic  neutrophilia,  mimicking  chronic 
neutrophilic  leukemia  (CNL).  Patients  with  CNL  have  a  poor  prognosis;  therefore,  it  is 
important to distinguish diagnostically between CNL and reactive neutrophilia.
Monoclonal  gammopathy  of 
undetermined significance (MGUS), as defined by 
the  International  Myeloma  Working  Group,  is  a 
disorder characterized by a prominent monoclonal 
protein  identified  by  serum  electrophoresis.    In 
MGUS,  the  serum  monoclonal  protein 
entration is <30 g/L and the incidence of bone 
marrow clonal cells is <10% with no evidence of 
multiple  myeloma.    MGUS  is  thought  to  be  a 
premalignant condition from which myeloma may 
arise;  indeed,  about  20%  of  patients with  MGUS 
will develop myeloma.
1
Chronic  neutrophilic  leukemia  (CNL)  is  an 
extremely  rare  entity,  which  is  as  yet  not  well 
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old  woman  with  a  medical  history  of  diabetes  mellitus, 
osteoporosis, peripheral vascular disease, and hypertension who had earlier presented at an 
outside facility with knee pain, which led to a finding of elevated neutrophil count of 35× 
cause she was otherwise asymptomatic but continued showing elevated neutrophil 
levels, she sought a second opinion at our facility. Serum protein immunoelectrophoresis with 
κ  monoclonal  gammopathy 
350 mg/dL) but relatively normal concentrations of 
250  mg/dL).  Using clonal 
analysis, we found a polyclonal expression pattern in all cell types analyzed. Comprehensive
up  for  multiple  myeloma  and  infectious  etiology  of  neutrophilia  was  negative.  We 
concluded that our patient’s neutrophilia may have been due to the underlying monoclonal 
gammopathy. This is the first case in the literature of a patient with monoclonal gammopathy 
of  undetermined  significance  presenting  with  chronic  neutrophilia,  mimicking  chronic 
neutrophilic  leukemia  (CNL).  Patients  with  CNL  have  a  poor  prognosis;  therefore,  it  is 
philia.
marrow clonal cells is <10% with no evidence of 
multiple  myeloma.    MGUS  is  thought  to  be  a 
premalignant condition from which myeloma may 
arise;  indeed,  about  20%  of  patients  with  MGUS 
Chronic  neutrophilic  leukemia  (CNL)  is  an 
extremely  rare  entity,  which  is  as  yet  not  well Medit J Hemat Infect Dis 2010; 2(1); Open Journal System 
defined.  The  main  defining  features  are 
splenomegaly  and a neutrophilic  predominance  in 
the peripheral blood, which cannot be explained by 
any  infectious  process  or  leukemoid  reaction.  In 
addition,  the  diagnosis  of  chronic  myelogenous 
leukemia must be excluded. There should also be 
evidence  of  B-cell  receptor  (BCR)  and  ABL 
negativity.
2 So far, no molecular markers specific to 
this  disorder  and  no  treatment  that  results in 
complete  remission  have  been  identified.  The 
prognosis for patients is poor, given the very few 
therapies  available  for  treatment,  and  the  disease 
may  become  refractory  to  treatment.  In  addition, 
this  disease  has  a  strong  potential  for  blastic 
transformation, which is often terminal for patients. 
Most  treatment  options  for  CNL,  namely, 
hydroxyurea,  busulfan,  and  6-thioguanine,  at  best 
only stabilize the neutrophilia.
Researchers  have  observed  an  association 
between CNL and monoclonal gammopathies such 
as MGUS or multiple myeloma.
3 Proposed theories 
for this association include the expression of high 
levels  of  cytokines,  such  as  IL-6,  produced  by 
plasma  cells, which may result in proliferation of 
other  myeloid  clones,
4 and  overproduction  of 
colony-stimulating  growth  factor  (G-CSF),  which 
may  induce  myeloid  growth.
5 In  this  report,  we 
present  a  unique  case  of  MGUS  with  leukemoid 
reaction disguised as CNL.
Case  Report:  In  December  2006,  a  60-year-old 
female patient, non-smoker, with a medical history 
of  diabetes  mellitus,  osteoporosis,  peripheral 
vascular disease, and hypertension presented to an 
outside facility with complaints of right knee pain. 
An  MRI  of  her  knee  showed  abnormal  bone 
marrow signaling. At presentation, complete blood 
cell counts were also made, showing white blood 
cell count of 44.11 × 10
9/L, with a differential of 
79%  neutrophils,  4%  lymphocytes,  and  no 
basophils.  Her  hemoglobin  concentration  was  14 
g/dL and platelet count was 158 × 10
9/L.  At initial 
presentation, she had no other complaints; however, 
on review of systems, she did recall a 3- to 4-month 
history  of  subjective  night  sweats,  along  with 
constipation  alternating  with  diarrhea.  Leukocyte 
alkaline  phosphatase  score  was  elevated  at  319 
(normal  25-130).    In  addition,  she  had  a  mildly 
elevated γ-globulin level of 3.9 g/dL, as well as an 
elevated level of β-microglobulin at 3.1 mg/L.  In 
January  2007,  the  patient’s  peripheral  blood 
underwent cytogenetic and FISH analyses for BCR 
and ABL; both tests were negative. PCR was also 
negative for BCR and ABL.  Bone marrow biopsy 
for  persistent  neutrophilia  showed  overall 
hypercellularity,  with  plasma  cell  percentage  7% 
and  normal  cytogenetics.  Computed  tomography 
imaging of the chest, abdomen, and pelvis showed 
no  significant  abnormalities,  including  a  normal 
spleen size at 11.3 cm.  She remained asymptomatic 
with neutrophilia for several months. In July 2007, 
the  patient  was  referred  to  our  institution  for  a 
second  opinion,  given  her  persistently  elevated 
neutrophil count (white blood cell count of 48.74 × 
10
9/L, with a differential of 92% neutrophils).
Repeat  FISH  and  RT-PCR  on  the  peripheral 
blood  were  both  negative  for  BCR/ABL;  JAK2-
V617F  mutation  was  also  negative.  Bone  survey 
and  spinal  MRI  were  negative  for  findings 
consistent with multiple myeloma. However, results 
of a repeat β2-microglobulin analysis showed that 
levels  were  still  elevated  at  2.1  mg/L.    Serum 
protein  immunoelectrophoresis  with  immune-
fixation  revealed  an  IgA-κ  monoclonal  gammo-
pathy concentration of 1305 mg/dL (normal 80-350 
mg/dL) and relatively normal concentrations of IgG 
of  840  mg/dL  (620-1400  mg/dL)  and  IgM  of  36 
mg/dL  (45-250  mg/dL).  Urine  protein  electro-
phoresis showed  an  M  spike  of  IgA heavy  chain 
with  mild  proteinuria.  Extensive  work-up  for 
infectious process and  a full  screening  evaluation 
for underlying occult neoplasm were both negative.
To  determine  the  clonal  origin  of  the 
hematopoietic cells in our patient, we employed a 
transcriptional  clonality  assay  based  on  exonic 
polymorphism  (C146T)  of  the  X-chromosome-
linked  gene  iduronate-2-sulfatase  (IDS).
6 Allele-
specific  PCR  was  used  to  detect  the  IDS  gene 
polymorphism,  by  extracting  and  amplifying  the 
DNA from the peripheral blood.  Mononuclear and 
polymorphonuclear  leukocytes  were  obtained  by 
differential centrifugation with Lympholyte
®–poly; 
platelets were obtained by high speed centrifugation 
of fresh plasma.  Per methods developed by Gregg 
et al.,
6 we amplified 3 ng of DNA using 250 pmol 
forward primer IDS1 and reverse primer IDS2R in
50  µL  of  PCR  product  with  1.25  Units  iTaq 
polymerase (Bio-Rad,  Hercules,  CA)  and reactant 
concentrations  suggested  for  the  enzyme.    Five 
microliters of this first PCR product were used for 
the  allele-specific  reaction  using  the  common 
reverse  primer  IDS2R and  the  specific  forward 
primers, either IDS3C or IDS4T, in 50 µL of PCR 
product.  The  products  were  analyzed  in  1.5% 
agarose  gel  with  0.4  µg/mL  ethidium  bromide to 
determine whether the sample was heterozygous for 
the  polymorphism  and  informative  for  clonality.
Because  our  patient  was  informative  for  thisMedit J Hemat Infect Dis 2010; 2(1); Open Journal System 
Fig. 1. (A) Determination of iduronate-2-sulfatase (IDS) genotype. “C wells” contain polymerase chain reaction (PCR) products 
primed  with  C-specific  oligonucleotide.  “T  wells”  contain  products  primed  with  T-specific  oligonucleotide.  The  patient  is 
heterozygote for the polymorphism (both bands). Control 1 is homozygous for C allele, and Control 2 is homozygous for T allele 
(single band). (B) Clonality analysis. Total RNA, obtained from peripheral blood polymorphonuclear cells (PMN), mononuclear cells 
(MONO), and platelets (PLT), was transcribed into cDNA. Allele-specific PCR analysis of transcripts of IDS gene detected both 
alleles (C, T) in all analyzed cell types, suggesting polyclonal hematopoiesis. -ive ctrl = Negative control; simultaneously processed 
sample with substitution of H2O for DNA.
polymorphism  (Figure 1A),  we  tested expression 
of the IDS allele in distinct hematopoietic lineages 
in  peripheral  blood.  Using  this  PCR  analysis,  a 
polyclonal  expression  pattern  was  found  in  all 
analyzed  cell  types  (granulocytes,  mononuclear 
cells, and platelets) (Figure 1B).
Based on the polyclonality, we concluded that 
our  patient’s  neutrophilia  was  most  probably 
secondary  to  the  underlying  monoclonal 
gammopathy.  The patient remained asymptomatic; 
therefore,  we  opted  to  monitor  her  closely  rather 
than initiate treatment.
Discussion: To  date,  there  have  been  only  6 
cases described in the literature of CNL associated 
with  MGUS.
7 This  association  may  arise  from  a 
defect  in  the  early  hematopoietic  stem  cells, 
suggesting  that  this  coexistence  may  be  one 
continuous  process,  rather  than  two  separate 
hematologic  malignancies.    In  this  case,  the 
association  is  caused  by  the  transformation  of  a 
pluripotent stem cell malignancy, which results in 
the proliferation of the two cell lines.
3 Although yet 
to be proven, this  theory could be applied to  our 
case.    Another  explanation  for  the  association 
between  CNL  and  MGUS  may  simply  be  the 
propensity  for  older  patients  to  develop  multiple 
malignancies.
Other  researchers
8 have  suggested  that  this 
phenomenon may be due to neutrophilic expansion 
as a response to cytokines released by plasma cells 
in  patients  with  a  monoclonal  gammopathy.
4 To 
support  this  theory,  there  have  been  reports  that, 
during  treatment  of  myeloma  in  patients  with 
concurrent CNL (as clonal disease), the neutrophilia 
also resolves. 
8,9 However, this theory fails to fully 
explain this relationship as some patients diagnosed 
with  CNL  have  no  concurrent  diagnosis  of
monoclonal gammopathy, even after years.
10 It also 
raises the question of why other cell lines were not 
also affected if this is a cytokine response.
In  our  patient,  the  possibility  exists  that  the 
neutrophilia may be a precursor to or indicator of 
the  eventual  development  of  her  monoclonal 
gammopathy.  She does not fulfill the criteria for 
CNL  as  described.    She  lacks  splenomegaly,  and 
her  neutrophils were  a  polyclonal population,  not 
monoclonal.  This suggests that the cells are non-
neoplastic in nature since they arise from different 
pregenitors.  In our case, one could postulate that 
the  neutrophilia  is related  to  the  monoclonal 
gammopathy  via  an  indirect  stimulatory  effect 
resulting  in  increased  release  of  endogenous  G-
CSF. Studies have indeed shown the existence of 
high serum levels of G-CSF in patients with plasma 
cell neoplasm.
5Unfortunately, due to loss of follow-
up, we were unable to obtain further blood samples 
from  the  patient  to  evaluate  whether  she  had 
elevated serum cytokine levels of G-CSF or IL-6. 
The  polyclonality  shown  in  our  patient  goes 
against a diagnosis of CNL.
11,12,13 The confirmation 
of polyclonality indicates the absence of mutation in 
a pluripotent stem cell and also negates the clonal 
origin  of  neutrophilia  and  thus  the  diagnosis  of 
CNL.    One  case  report,  by  Katsuki  et  al.
14, 
identified a patient in whom CNL transformed into 
an acute myeloblastic leukemia after 3 years. This 
resulted  in  death  of  the  patient  within  1  month, 
hence  the  importance  of  truly  determining  the 
disease  entity  as  CNL  versus  leukemoid  reaction 
resulting in neutrophilia.
Our  case  exhibits  some  similarity  to  that
described by Stevenson et al.,
15 in which a patient 
with IgA multiple myeloma and neutrophilia 1 year 
later developed myelofibrosis; however, in our case 
the neutrophilia may be secondary to IgA MGUS, 
not myeloma; in addition, our patient has no history 
of developing myelofibrosis. Based on the evidence 
that the neutrophilia in our patient could be reactive 
secondary  to  evolving  plasma  cell  disorder,  it  is 
possible that eventual treatment of the MGUS could 
result in resolution of the neutrophilia. Medit J Hemat Infect Dis 2009; 1: Open Journal System
References
1. The    International  Myeloma  Working  Group.  Criteria  for  the 
classification  of  monoclonal  gammopathies,  multiple  myeloma 
and  related  disorders:  a  report  of  the  International  Myeloma 
Working Group. Br J Haematol. 2003; 121:749-757. 
2. Jaffe  ES,  Harris  NL,  Stein H,  Vardiman  JW.  World  Health 
Organization classification of tumours: pathology and genetics of 
tumours  of  hematopoietic  and  lymphoid  tissues.  Lyon,  France, 
IARC Press. 2001. 
3. Dinçol G, Nalçaci M, Doğan O, Aktan M, Küçükkaya R, Ağan M, 
Dinçol  K.  Coexistence  of  chronic  neutrophilic  leukemia  with 
multiple myeloma. Leuk Lymphoma. 2002; 43:649-651. 
4. Standen  GR,  Jasani  B,  Wagstaff  M,  Wardrop  CAJ.  Chronic 
neutrophilic leukemia and multiple myeloma: an association with 
λ light chain expression. Cancer. 1990; 66:162-166. 
5. Nagai M, Oda S, Iwamoto M, Marumoto K, Fujita M, Takahara J. 
Granulocyte-colony stimulating factor concentrations in a patient 
with  plasma  cell  dyscrasia  and  clinical  features  of  chronic 
neutrophilic leukaemia. J Clin Pathol. 1996; 49:858-860. 
6. Gregg XT, Kralovics R, Prchal JT. A polymorphism of the X-
linked gene IDS increases the number of females informative for 
transcriptional clonality assays. Am J Hematol. 2000; 63:184-191. 
7. Ito T, Kojima H, Otani K, Komeno T, Mitsuhashi S, Hasegawa Y, 
Kobayashi  T,  Ninomiya  H,  Nagasawa  T,  Abe  T.  Chronic 
neutrophilic leukemia associated with monoclonal gammopathy of 
undetermined significance. Acta Haematol. 1996; 95:140-143. 
8. Elliot  MA,  Dewald  GW,  Tefferi  A,  Hanson  CA.  Chronic 
neutrophilic  leukemia  (CNL):  a  clinical,  pathologic  and 
cytogenetic study. Leukemia. 2001; 15:35-40. 
9. Standen GR, Steers FL, Jones L. Clonality of chronic neutrophilic 
leukaemia associated with myeloma: analysis using the X-linked 
probe M27β. J Clin Pathol. 1992; 46:297-298. 
10. Franchi F, Seminara P, Giunchi G. Chronic neutrophilic leukemia 
and myeloma: report on long survival. Tumori. 1984; 70:105-107. 
11. Bohm J, Kock S, Schaefer HE, Fisch P. Evidence of clonality in 
chronic neutrophilic leukaemia. J Clin Pathol. 2003; 56:292-295. 
12. Kwong  YL,  Cheng  G.  Clonal  nature  of  chronic  neutrophilic 
leukemia. Blood. 1993; 82:1035-1036. 
13. Matano S, Nakamura S, Kobayashi K. Deletion of the long arm of 
chromosome 20 in a patient with chronic neutrophilic leukemia: 
cytogenetic  findings  in  chronic  neutrophilic  leukemia.  Am  J 
Hematol. 1997; 54:72-75. 
14. Katsuki  K,  Shinohara  K,  Takeda  K,  Ariyoshi  K,  Yamada  T, 
Kameda  N,  Takahashi  T,  Nawata  R,  Shibata  S,  Asano  Y, 
Okamura  S.  Chronic  neutrophilic  leukemia  with  acute 
myeloblastic transformation. Jpn J Clin Oncol. 2000; 30:362-365. 
15. Stevenson  JP,  Schwarting  R,  Schuster  S.  Analysis  of  clonality 
using  X-linked  polymorphisms  in  a  patient  with  multiple 
myeloma  and  myelofibrosis.  Am  J Hematol.  1998;  59:79-82. 